Metastatic HER2+ Breast Cancer: A Potentially Curable Disease?

The advent of trastuzumab and other human epidermal growth factor receptor 2 (HER2)-directed therapies has revolutionized the treatment of metastatic HER2-positive breast cancer, leading to prolonged survival and appreciable clinical benefit for a substantial subset of patients. Previously, in a ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Prior, Lisa, Lim, Marvin, Ward, Cian, Featherstone, Hannah, Murray, Hazel, D'Arcy, Clare, Crown, John, Gullo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669532/
https://www.ncbi.nlm.nih.gov/pubmed/29142802
http://dx.doi.org/10.7759/cureus.1654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669532/
https://www.ncbi.nlm.nih.gov/pubmed/29142802
http://dx.doi.org/10.7759/cureus.1654

Ejemplares similares